The integrin αvβ6 is a promising target for the therapy of PDAC: toward phase I trials

✍ Scribed by Vallath, S.; Scarpa, A.; Weinreb, P.; Violette, S.; Steele, C.; Morton, J.; Sansom, O.; Davies, J.; Meyer, T.; Barry, S.; Kocher, H.M.; Marshall, J.F.

• Book ID: 124118827
• Publisher: S. Karger AG
• Year: 2014
• Tongue: English
• Weight: 52 KB
• Volume: 14
• Category: Article
• ISSN: 1424-3903
• DOI: 10.1016/j.pan.2014.03.012